tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market
FATE
Fate Therapeutics
RESEARCH TOOLSreports
Want to see FATE full AI Analyst Report?

Fate Therapeutics (FATE) Income Statement

1,267 Followers

Fate Therapeutics Income Statement

Last quarter (Q4 2025), Fate Therapeutics's total revenue was $1.37M, a decrease of -26.40% from the same quarter last year. In Q4, Fate Therapeutics's net income was $-32.37M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.65M$ 13.63M$ 63.53M$ 96.30M$ 55.85M
Gross Profit
$ -6.25M$ 13.63M$ -93.65M$ 82.54M$ 50.00M
Operating Expenses
$ 141.45M$ 223.91M$ 96.86M$ 390.93M$ 266.99M
Depreciation and Amortization
$ 9.29M$ 18.96M$ 18.28M$ 13.76M$ 5.85M
EBITDA
$ -127.02M$ -176.58M$ -172.23M$ -294.63M$ -211.14M
Operating Income
$ -147.70M$ -210.28M$ -190.51M$ -308.39M$ -216.99M
Other Income/Expenses
$ 11.39M$ 24.01M$ 29.58M$ 26.66M$ 4.84M
Pretax Income
$ -136.31M$ -186.26M$ -160.93M$ -281.72M$ -212.15M
Net Income
$ -136.31M$ -186.26M$ -160.93M$ -281.72M$ -212.15M
Per Share Metrics
Basic EPS
$ -1.15$ -1.64$ -1.64$ -2.91$ -2.24
Diluted EPS
$ -1.15$ -1.64$ -1.64$ -2.91$ -2.24
Weighted Average Shares Outstanding
 118.79M 113.69M 98.41M 96.83M 94.75M
Weighted Average Shares Outstanding (Diluted)
 118.79M 113.69M 98.41M 96.83M 94.75M
Currency in USD

Fate Therapeutics Earnings and Revenue History